Related Experiment Video
Updated: Sep 21, 2025

TGF-β-mediated Endothelial to Mesenchymal Transition EndMT and the Functional Assessment of EndMT Effectors using CRISPR/Cas9 Gene Editing
Published on: February 26, 2021
MiR-130a-5p contributed to the progression of endothelial cell injury by regulating FAS
Wei Wang1, Wenbo Tang2, Erbo Shan3
1The First Clinical College of Jinan University, Guangzhou, and Surgical Oncology Department, the Second Affiliated Hospital of Bengbu Medical College, Bengbu. wangwei@bbmc.edu.cn.
Abstract:
MicroRNAs (miRNAs) play critical roles in the development of vascular diseases. However, the effects of miR-130a-5p and its functional targets on atherosclerosis (AS) are still largely unknown. In this regard, our aim is to explore the potentially important role of miR-130a-5p and its target gene during the progression of endothelial cell injury. We first found oxidized low-density lipoprotein (ox-LDL) induced FAS and cell apoptosis in HUVECs. Subsequently, miR-130a-5p expression was verified to be downregulated after ox-LDL treatment and negatively correlated with FAS, and FAS was identified as substantially upregulated in the ox-LDL-treated HUVEC cells. After that, the knockdown of FAS and overexpression of miR-130a-5p together were observed to aggregate ox-LDL-induced reduction of cell viability and apoptosis, cell cycle progression, cell proliferation, cell migration and invasion. In conclusion, we detected that miR-130a-5p contributed to the progression of endothelial cell injury by regulating of FAS, which may provide a new and promising therapeutic target for AS.
Insights
MicroRNA miR-130a-5p regulates FAS to impact endothelial cell injury in atherosclerosis. Downregulation of miR-130a-5p exacerbates oxidized low-density lipoprotein-induced damage, suggesting a therapeutic target for vascular disease.
Area of Science:
- Molecular Biology
- Cardiovascular Research
- Cell Biology
Background:
- MicroRNAs (miRNAs) are crucial in vascular disease development.
- The specific role of miR-130a-5p and its targets in atherosclerosis (AS) remains unclear.
- Endothelial cell injury is a key factor in AS pathogenesis.
Purpose of the Study:
- To investigate the role of miR-130a-5p and its target gene in endothelial cell injury.
- To elucidate the mechanism by which miR-130a-5p influences atherosclerosis progression.
Main Methods:
- Oxidized low-density lipoprotein (ox-LDL) was used to induce injury in human umbilical vein endothelial cells (HUVECs).
- Expression levels of miR-130a-5p and FAS were measured.
- Cell viability, apoptosis, cell cycle, proliferation, migration, and invasion assays were performed.
- FAS knockdown and miR-130a-5p overexpression were utilized.
Main Results:
- Ox-LDL induced FAS expression and apoptosis in HUVECs.
- miR-130a-5p expression decreased following ox-LDL treatment and was negatively correlated with FAS.
- FAS expression was upregulated in ox-LDL-treated HUVECs.
- Combined knockdown of FAS and overexpression of miR-130a-5p aggravated ox-LDL-induced detrimental effects on endothelial cells.
Conclusions:
- miR-130a-5p contributes to endothelial cell injury by regulating FAS.
- This miR-130a-5p/FAS pathway presents a potential therapeutic target for atherosclerosis.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Intracellular Signaling Affects Focal Adhesions
Some...
MAPK Signaling Cascades
The Extrinsic Apoptotic Pathway
TGF - β Signaling Pathway

